» Authors » David L Caraway

David L Caraway

Explore the profile of David L Caraway including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 696
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Raji O, Tandio J, Mayer S, Escobar A, Himmelwright B, Beall D, et al.
Med Devices (Auckl) . 2024 Oct; 17:385-399. PMID: 39473777
Purpose: To concurrently assess and compare the fixation efficacy, invasiveness, and fusion potential of a posterior integrated transfixation cage system to the posterolateral threaded implant and lateral triangular rod systems,...
2.
Petersen E, Stauss T, Scowcroft J, Jaasma M, Edgar D, White J, et al.
J Diabetes Sci Technol . 2024 Oct; :19322968241268547. PMID: 39369310
Background: The SENZA-PDN study evaluated high-frequency 10-kHz spinal cord stimulation (SCS) for the treatment of painful diabetic neuropathy (PDN). Over 24 months, 10-kHz SCS provided sustained pain relief and improved...
3.
Klonoff D, Levy B, Jaasma M, Bharara M, Edgar D, Nasr C, et al.
J Pain Res . 2024 Sep; 17:3063-3074. PMID: 39308991
Purpose: The recent SENZA-PDN study showed that high-frequency (10kHz) spinal cord stimulation (SCS) provided significant, durable pain relief for individuals with painful diabetic neuropathy (PDN), along with secondary benefits, including...
4.
Argoff C, Armstrong D, Kagan Z, Jaasma M, Bharara M, Bradley K, et al.
J Diabetes Sci Technol . 2024 Jan; :19322968231222271. PMID: 38193426
Background: Painful diabetic neuropathy (PDN) can result in the loss of protective sensation, in which people are at twice the likelihood of foot ulceration and three times the risk of...
5.
Taylor R, Lad S, White J, Stauss T, Healey B, Sacks N, et al.
J Manag Care Spec Pharm . 2023 Aug; 29(9):1021-1029. PMID: 37610114
Diabetic peripheral neuropathy, a common comorbidity of diabetes, is a neurodegenerative disorder that targets sensory, autonomic, and motor nerves frequently associated with painful diabetic neuropathy (PDN). PDN carries an economic...
6.
Petersen E, Stauss T, Scowcroft J, Jaasma M, Brooks E, Edgar D, et al.
Diabetes Res Clin Pract . 2023 Aug; 203:110865. PMID: 37536514
Aims: To evaluate the long-term efficacy of high-frequency (10 kHz) spinal cord stimulation (SCS) for treating refractory painful diabetic neuropathy (PDN). Methods: The SENZA-PDN study was a prospective, multicenter, randomized...
7.
Petersen E, Stauss T, Scowcroft J, Brooks E, White J, Sills S, et al.
Mayo Clin Proc Innov Qual Outcomes . 2022 Jul; 6(4):347-360. PMID: 35814185
Objective: To evaluate high-frequency (10-kHz) spinal cord stimulation (SCS) treatment in refractory painful diabetic neuropathy. Patients And Methods: A prospective, multicenter randomized controlled trial was conducted between Aug 28, 2017...
8.
9.
Chen J, Hesseltine A, Nashi S, Sills S, McJunkin T, Patil S, et al.
J Diabetes Sci Technol . 2021 Nov; 16(2):282-288. PMID: 34842489
Background: Diabetes is one of the most prevalent chronic health conditions and diabetic neuropathy one of its most prevalent and debilitating complications. While there are treatments available for painful diabetic...
10.
Petersen E, Stauss T, Scowcroft J, Brooks E, White J, Sills S, et al.
JAMA Neurol . 2021 Apr; 78(6):687-698. PMID: 33818600
Importance: Many patients with diabetic peripheral neuropathy experience chronic pain and inadequate relief despite best available medical treatments. Objective: To determine whether 10-kHz spinal cord stimulation (SCS) improves outcomes for...